These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 10675820)

  • 1. [Chemotherapy, combined radiochemotherapy and new therapeutic approaches in adenocarcinoma of the pancreas].
    André T; Balosso J
    J Chir (Paris); 1999 Dec; 136(6):309-17. PubMed ID: 10675820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemoradiation for pancreatic adenocarcinoma].
    Flandin I; Mornex F; Claude L; Kubas A; Khodri M; Wautot V; Mazeron R; Partensky C
    Cancer Radiother; 2004 Nov; 8 Suppl 1():S80-7. PubMed ID: 15679252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adjuvant treatment of pancreatic cancer].
    Oettle H
    Zentralbl Chir; 2003 May; 128(5):411-8. PubMed ID: 12813641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adjuvant and additive therapy for cancer of the pancreas].
    Neoptolemos JP; Raraty MG; Ghaneh P; Hickey H; Stocken DD; Dunn JA; Friess H; Büchler MW
    Chirurg; 2003 Mar; 74(3):191-201. PubMed ID: 12647075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gemcitabine and pancreatic cancer].
    Prost P; Ychou M; Azria D
    Bull Cancer; 2002 Aug; 89 Spec No():S91-5. PubMed ID: 12449037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Adenocarcinoma of the exocrine pancreas: management and therapeutic hopes].
    Caudry M; Bonnel C
    Rev Med Interne; 1999 Sep; 20(9):810-5. PubMed ID: 10522305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy, chemoradiotherapy or observation after complete resection of pancreatic adenocarcinoma?].
    Lluís F
    Gastroenterol Hepatol; 2009 Feb; 32(2):120-1. PubMed ID: 19231687
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of locally advanced adenocarcinoma of the pancreas.
    Ryan DP; Willett CG
    Hematol Oncol Clin North Am; 2002 Feb; 16(1):95-103. PubMed ID: 12063831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant treatment of oesophageal adenocarcinoma.
    Robb WB; Naughton P; Walsh TN
    Minerva Chir; 2004 Oct; 59(5):461-70. PubMed ID: 15494673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
    Dunst J; Haensgen G
    Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radiochemotherapy with gemcitabine and cisplatin in pancreatic cancer -- feasible and effective].
    Wilkowski R; Thoma M; Heinemann V; Rau HG; Wagner A; Stoffregen C; Dühmke E
    Strahlenther Onkol; 2003 Feb; 179(2):78-86. PubMed ID: 12590317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging drugs in pancreatic cancer.
    Ducreux M; Boige V; Malka D
    Expert Opin Emerg Drugs; 2004 May; 9(1):73-89. PubMed ID: 15155137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.
    Ettrich TJ; Berger AW; Perkhofer L; Daum S; König A; Dickhut A; Wittel U; Wille K; Geissler M; Algül H; Gallmeier E; Atzpodien J; Kornmann M; Muche R; Prasnikar N; Tannapfel A; Reinacher-Schick A; Uhl W; Seufferlein T
    BMC Cancer; 2018 Dec; 18(1):1298. PubMed ID: 30594153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radically resected pancreatic cancer and adjuvant treatment. A review of the literature].
    Drudi F; Tassinari D; Giuliani J; Ridolfi C; Gianni L; Tamburini E; Fantini M; Santelmo C; Barzotti E; Lotti N; Ravaioli A
    Recenti Prog Med; 2013 Feb; 104(2):80-5. PubMed ID: 23535964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inoperable pancreatic cancer: standard of care.
    Wisinski KB; Wahl AO; Small W; Benson AB
    Oncology (Williston Park); 2007 Nov; 21(13):1558-64; discussion 1565, 1570-2. PubMed ID: 18179046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of multimodal treatment for patients with resectable carcinoma of the pancreas.
    Okabayashi T; Nishimori I; Nishioka A; Yamashita K; Sugimoto T; Dabanaka K; Maeda H; Kohsaki T; Ogawa Y; Kobayashi M; Onishi S; Hanazaki K
    Oncol Rep; 2008 Sep; 20(3):651-6. PubMed ID: 18695919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic cancer. The relative importance of neoadjuvant therapy].
    Beger HG; Poch B; Schwarz M; Gansauge F
    Chirurg; 2003 Mar; 74(3):202-7. PubMed ID: 12647076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced and metastatic pancreatic cancer.
    Blaszkowsky L
    Front Biosci; 1998 Nov; 3():E214-25. PubMed ID: 9792894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adenocarcinoma of the pancreas. Therapeutic strategies].
    André T; Balosso J; Louvet C; Houry S; Vaillant JC; Touboul E; Lotz JP; de Gramont A; Izrael V
    Presse Med; 1998 Mar; 27(11):539-45. PubMed ID: 9767970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.